Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/452462


Confronting the Bioprocessing Challenge


Description: In the early 2000s, an anticipated shortfall in protein production capacity was averted thanks to breakthroughs in manufacturing approaches and technologies. Today, new challenges and bottlenecks threaten the cost-effective and adequate manufacture of protein therapeutics, which constituted a roughly $68 billion market in 2006. Again, new manufacturing approaches and a host of technological developments promise to address these issues.

Get the Answers You Need to Shape Your Strategy

Growing demand for protein-based therapeutics, particularly MAbs, has encouraged manufacturers of these drugs to rapidly expand their production capacity. Which companies have built or are planning to build additional biopharmaceutical manufacturing capacity? What factors influence the decision to expand or add new facilities? The need for increased bioprocessing capacity has spawned a market for contract manufacturing organizations. How large is this new industry? How can it serve the biopharma industry? What are the leading CMOs? Manufacturers have several strategic options for sidestepping bottlenecks and rising costs. How can they influence upstream and downstream production processes? What new technologies (e.g., non-mammalian cell lines, disposable purification devices) will make a difference in throughput?

Scope

- Recombinant proteins and monoclonal antibodies: processes and challenges for their manufacture, trends in approvals and sales.
- Mammalian cell culture: Mammalian cell lines and non-mammalian alternatives, bioreactor technology, media formulation, glycosylation.
- Protein purification: Clarification and filtration, affinity ligands, hydroxyapatite purification, disposable purification devices.


Contents: Executive Summary
Strategic Considerations
Stakeholder Implications
Introduction
Biomanufacturing Overview
The Production Process
Regulatory Considerations
No Shortfall in Production Capacity
Expansion of Manufacturing Capacity
Fewer Approvals Than Expected
Improved Technologies, Higher Yields
Upstream Processes: Mammalian Cell Culture Production
Mammalian Cell Lines
Bioreactor Technology
Bioreactor Hardware
Microcarriers
Disposables
Media Formulation
Glycosylation
Downstream Processes: Protein Purification
Clarification and Filtration
Affinity Ligands
Hydroxyapatite Purification
Disposable Purification Devices
Outlook for Biomanufacturing
Manufacturing Options
Pushing the Limits of Production
Alternative Expression Systems
Importance of Disposables

Tables
1. Increases in Therapeutic Protein Manufacturing Capacity
2. Contract Manufacturers of Recombinant Proteins and Monoclonal Antibodies
3. Marketed Therapeutic Monoclonal Antibodies
4. Protein Expression Platforms

Figures
1. Worldwide Sales of Recombinant Therapeutic Proteins and Therapeutic Monoclonal Antibodies
2. General Bioprocessing Scheme
3. U.S. Monoclonal Antibody Approvals, 1997-2006


Companies Mentioned Abbott Bioresearch Center A-Bio Affinity Life Sciences Amersham Bioscience Amgen Avecia Avid Bioservices Baxter Biopharma Solutions Biocon Biogen Idec BioInvent International Biolex Therapeutics Bio-Rad BioReliance Boehringer Ingelheim Bristol-Myers Squibb Cangene Cardinal Health Cellectis Celliance Celltrion Centocor Chromos Molecular Systems Chugai CMC Biopharmaceuticals Cobra Biologics Cook Pharmica Corixa Crucell Daiichi Asubio Pharma Dainippon Sumitomo Diosynth Biotechnology Dowpharma DSM Biologics Elan Pharma Eli Lilly Eurogentec Florida Biologix Fluorometrix Gala Biotech GE Healthcare Genentech Genzyme Flanders GlaxoSmithKline Glycart GlycoFi Glycotope Goodwin Biotechnology HyClone IBA Biologics Imclone Systems Invitrogen Bioservices Johnson & Johnson Laureate Pharma


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/452462

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 05/09/2008 09:24:24
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Confronting the Bioprocessing Challenge

Web Address:
http://www.researchandmarkets.com/reports/452462

Office Code:
OCHHGHMLMTU

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,528.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 05/09/2008 09:24:24


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World